Assessment Of Quality Of Life And Modulating The Diet And Drug Interventions A Paradigm Shift
Keywords:
No KeywordsAbstract
Objectives: We evaluated Quality of Life(QOL) parameter for the care of people with diabetes. Method: We conducted a prospective study and evaluated QOL using QOL Instrument for Indian Diabetes (QOLID) patient's questionnaire, comprising 8 domains, 34 items, in 369 consecutive patients as a single point assessment tool. We calculated percentage score for each domain and mean value formed basis for calculation of weighted score. Descriptive statistics was used for analysis. Results: 369 patients were administered the QOLID (173 males, 196 females). Mean age was 59 years (range 19- 81, SD ± 11,95% Cl 58 to 60). Mean HbAlc was 8.1 % (range 5.3-16, SD ± 1.6,95% Cl 7.9 to 8.3). Notably, 278 patients had HbAlc > 7. 26%. 91 patients had HbAlc <7. Mean duration of diabetes was 11 years (range 0.2 -40, SD ± 7.8,95% Cl 10 to 12). Mean duration of follow up since first visit was 25 months (range 1-44, SD± 12,95% Cl 24 to 27). Mean number of visits were 7.7 (range 1-25, SD± 3.7,95% Cl 7.4 to 8.1). 89.7 % (n=331) were exclusively on OHA, 26 patients were both on OHA and insulin and only 12 patients were exclusively on lifestyle modification.Downloads
Published
How to Cite
Issue
Section
References
Skevington SM, Lotfy M, O'Connell KA. The World Health Organization's WHOQOL-BREF quality of life assessment:
psychometric properties and results of the international field trial. A report from the WHOQOL group. Quality of Life Research 2004; 13:299-310.26. Rubin RR, Peyrot M.
. Quality of life and diabetes. Diabetes/Metaholism Research and Reviews 1999; 15:205-18.27.
Testa MA. Quality-of-life assessment in diabetes research: interpretin g the magnitude and meaning of treatment effects. Diabetes Spectrum 2000; 13:29.28.
American Diabetes Association. Quality of life in type 2 diabetic patients is affected by complications but not by intensive policies to improve blood glucose or blood pressure control (UKPDS 37). UK Prospective Diabetes Study Group. Diabetes Care 1999; 22:112536.
Glycemic Pentad Forum. Glycemic Pentad. Journal of The Association of Physicians of India 2017:65
Ceriello A. The glucose triad and its role in comprehensive glycemic control: current status, future management. International Journal of Clinical Practice 2010; 64:1705-11
American Diabetes Association. Promoting health and reducing disparities in populations. Standards of Medical Care in Diabetes 2017. Diabetes Care 2017; 40.
Monnier L, Lapinsk i H, Colette C. Contributions of fasting and postprandial plasma glucose increments to the overall diurnal hyperglycemia of type 2 diabetic patients. Diabetes Care 2003; 26:881-5
Jitender Nagpal. The Development of 'Quality of Life Instrument for Indian Diabetes Patients (QOLID): A Validation and Reliability Study in Middle and Higher Income Groups.JAPI;2010:58
International Diabetes Federation. Clinical Guidelines Task Force Global Guideline for Type 2 Diabetes, 2012, Available at http://www.idf.org/sites/default/files/IDFGuideline-for-Type-2-Diabetes.pdf